Immunotherapy Vaccine for Mesothelioma Gets High Marks
Researchers say immunotherapy vaccine CRS-207 may soon become a standard-of-care treatment for mesothelioma.
Researchers say immunotherapy vaccine CRS-207 may soon become a standard-of-care treatment for mesothelioma.
Johns Hopkins’ Bloomberg–Kimmel Institute for Cancer Immunotherapy in Baltimore will advance mesothelioma treatment.
Thoracic surgeon Dr. Wickii Vigneswaran brings decades of experience treating mesothelioma to the Loyola University Health System.
The clinical trial seeks to find how freezing mesothelioma tumors before surgery will stimulate the immune system.
Take a look back at the best mesothelioma news of 2015, from survivor stories to the latest in treatment options and new specialty centers.
Specialists using SMART approach to mesothelioma treatment in Toronto are showing impressive results.